RecruitingNot ApplicableNCT07420231

Evaluation of the Synergistic Effect of Combining a Prebiotic and a Postbiotic on Intestinal Discomfort

Sponsor

Université Catholique de Louvain

Enrollment

140 participants

Start Date

Mar 16, 2026

Study Type

INTERVENTIONAL

Conditions

Intestinal Discomfort Abdominal Pain/ Discomfort

Summary

This study aims to investigate the beneficial effects of the daily consumption of a synbiotic formulation-combining a prebiotic (Berberine, BBR) and a postbiotic (inactivated Bifidobacterium Longum, B.longum)-in adults experiencing intestinal discomfort.

Eligibility

Min Age: 18 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Berberine, Bifidobacterium longum, and others for people with abdominal pain/ discomfort and intestinal discomfort. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 75 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTBerberine

The study foresees the intake of 3 capsules per day during 8 weeks

DIETARY_SUPPLEMENTBifidobacterium longum

The study foresees the intake of 3 capsules per day during 8 weeks

DIETARY_SUPPLEMENTBifidobacterium longum and Berberine

The study foresees the intake of 3 capsules per day during 8 weeks

DIETARY_SUPPLEMENTPlacebo

The study foresees the intake of 3 capsules per day during 8 weeks

Locations(1)

Center of Investigation in Clinical Nutrition (CICN)

Louvain-la-Neuve, Brabant Wallon, Belgium

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07420231